342 related articles for article (PubMed ID: 9135572)
1. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
Strandell E; Sandler S
J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent sensitivity to streptozotocin of pancreatic islets isolated from female NOD mice.
Reddy S; Sandler S
Autoimmunity; 1995; 22(2):121-6. PubMed ID: 8722582
[TBL] [Abstract][Full Text] [Related]
3. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
4. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
Sternesjö J; Sandler S
J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
Qian FY; Ouyang F; Fu DX; Ren TR
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
7. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
Strandell E; Eizirik DL; Sandler S
J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
[TBL] [Abstract][Full Text] [Related]
8. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells.
Andersson AK; Sandler S
J Pineal Res; 2001 Apr; 30(3):157-65. PubMed ID: 11316326
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice.
Welsh M; Welsh N; Bendtzen K; Mares J; Strandell E; Oberg C; Sandler S
Diabetologia; 1995 Feb; 38(2):153-60. PubMed ID: 7536171
[TBL] [Abstract][Full Text] [Related]
10. Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice.
Karlsson E; Stridsberg M; Sandler S
Regul Pept; 1996 May; 63(1):39-45. PubMed ID: 8795087
[TBL] [Abstract][Full Text] [Related]
11. Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.
Strandell E; Sandler S; Boitard C; Eizirik DL
Diabetologia; 1992 Oct; 35(10):924-31. PubMed ID: 1451948
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice.
Hill DJ; Petrik J; Arany E; McDonald TJ; Delovitch TL
J Endocrinol; 1999 Apr; 161(1):153-65. PubMed ID: 10194539
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
[TBL] [Abstract][Full Text] [Related]
16. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
Sternesjö J; Sandler S
Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
[TBL] [Abstract][Full Text] [Related]
18. Acute exposure to streptozotocin but not human proinflammatory cytokines impairs neonatal porcine islet insulin secretion in vitro but not in vivo.
Harb G; Toreson J; Dufour J; Korbutt G
Xenotransplantation; 2007 Nov; 14(6):580-90. PubMed ID: 17991146
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.
Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Arafat HA
J Endocrinol; 2005 Nov; 187(2):237-47. PubMed ID: 16293771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
